openPR Logo
Press release

Description of IP dust and water resistance levels

11-18-2024 07:04 PM CET | Industry, Real Estate & Construction

Press release from: ABNewswire

In industrial production, especially for electronic and electrical products used outdoors, dust and water resistance are critical. This capability is usually evaluated by the enclosure protection level of automated instruments and equipment, also known as the IP code. The IP code is the abbreviation of the international protection level, which is used to evaluate the protection performance of the equipment enclosure, mainly covering the two categories of dust and water resistance. Its testing machine [https://www.ubytestequipment.com/abrasion-test-machine/] is an indispensable and important testing instrument in the process of researching and exploring new materials, new processes, new technologies and new structures. It plays an important role in the effective use of materials, improving processes, improving product quality, reducing costs, and ensuring product safety and reliability.

Image: https://www.ubytestequipment.com/uploads/Description-of-IP-dust-and-water-resistance-levels.jpg Image: https://www.ubytestequipment.com/uploads/Description-of-IP-dust-and-water-resistance-levels-1-1.jpg

The IP dust and water resistance level is a standard for the protection capability of the device shell established by the International Electrotechnical Commission (IEC), usually referred to as the "IP level". Its English name is "Ingress Protection" or "International Protection" level. It consists of two numbers, the first number indicates the dust resistance level, and the second number indicates the water resistance level. For example: the protection level is IP65, IP is the marking letter, the number 6 is the first marking number, and 5 is the second marking number. The first marking number indicates the dust resistance level, and the second marking number indicates the water resistance protection level.

In addition, when the level of protection required is higher than the level represented by the above characteristic numerals, the extended scope will be expressed by adding additional letters after the first two digits, and it is also necessary to meet the requirements of these additional letters.

Media Contact
Company Name: Uby Industrial Co., Ltd.
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=description-of-ip-dust-and-water-resistance-levels]
Country: China
Website: https://www.ubytestequipment.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Description of IP dust and water resistance levels here

News-ID: 3742007 • Views:

More Releases from ABNewswire

Polycythemia Vera Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Roche, Fujifilm Holdings Corp, Hangzhou Bensheng Pharma, Protagonist Therapeu
Polycythemia Vera Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Polycythemia Vera pipeline constitutes 8+ key companies continuously working towards developing 10+ Polycythemia Vera treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Polycythemia Vera Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed
Myelofibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Keros
Myelofibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsigh …
The Key Myelofibrosis Companies in the market include - Lynk Pharmaceuticals, Samus Therapeutics, Taiga Biotechnologies, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Inc., Keros Therapeutics, Inc., Galecto Biotech AB, Actuate Therapeutics Inc., Karyopharm Therapeutics, AbbVie, Sierra Oncology, and others. DelveInsight's "Myelofibrosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Myelofibrosis, historical and forecasted epidemiology as well as the Myelofibrosis market trends in the United States, EU4 (Germany, Spain,
Asthma Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | GSK, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma, Genentec
Asthma Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Obser …
The Key Asthma Companies in the market inlcude - GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharmaceuticals, Inc., AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharmaceuticals, Genentech Research, Roche, Suzhou Connect Biopharmaceuticals, Avalo Therapeutics, 4D Pharma plc, Regeneron Pharmaceuticals, RAPT Therapeutics, Inc., Incyte Corporation, Areteia Therapeutics, Suzhou Connect Biopharmaceuticals, Ltd., Cumberland Pharmaceuticals, Pulmatrix Inc., and others. DelveInsight's "Asthma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Asthma, historical and
Inflammatory Bowel Disease Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | AbbVie, Janssen Pharma, Abivax, Morphic Therapeutic, Eli Lilly and Company, Gilead
Inflammatory Bowel Disease Market Positioned for Accelerated Development Through …
The Key Inflammatory Bowel Disease Companies: AbbVie, Janssen Pharmaceuticals, Abivax, Morphic Therapeutic, CJ Bioscience/4D Pharma, RedHill Biopharma, Tryp Therapeutics, Eli Lilly and Company, Gilead, Galapagos, Applied Molecular Transport, Protagonist Therapeutics, Janssen, AstraZeneca, Vifor Pharma, Astellas Pharma, Shield Therapeutics, Takeda, Ocera Therapeutics, Sanofi, Morphic Therapeutic, Inc., Bausch Health Americas, Inc., Qu Biologics Inc., Vifor Pharma, and others DelveInsight's "Inflammatory Bowel Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding

All 5 Releases


More Releases for Image:

Image Consulting Market Outlook, Trend Analysis, Current Growth, Future Scope An …
The latest report published by Coherent Market Insights highlights the growth prospects of the Image Consulting Market from 2025 to 2032. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. The market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The market study includes information on market factors such
Image Sensor Market: Image Sensor Growth to USD 39B by 2031
Image Sensor Market Scope: Key Insights : Image Sensor Market size was valued at USD 16.01 billion in 2022 and is poised to grow from USD 16.36 billion in 2023 to USD 39 billion by 2031, growing at a CAGR of 9.6% in the forecast period (2024-2031). Discover Your Competitive Edge with a Free Sample Report :https://www.skyquestt.com/sample-request/image-sensor-market Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/image-sensor-market In-Depth Exploration of the
Image Consulting Market: Opportunities in Executive Coaching, Wardrobe and Style …
Description Coherent Market insights announces the release of the report "Image Consulting Market - Demand, Growth, Opportunities and Analysis of Top Key Player Forecast to 2030", The Image Consulting market research report provides a comprehensive analysis of the current state and future potential of the Image Consulting market. The report covers various aspects, including market size, growth trends, key players, market segmentation, competitive landscape, industry drivers, and challenges. The objective of
CMOS and sCMOS Image Sensors CMOS and sCMOS Image Sensors
The latest CMOS and sCMOS Image Sensors market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thorough analysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. Request a sample on this latest research report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5096977 Top Key Players are covered in this report:
Interventional Image-Guided Systems Market Report 2018: Segmentation by Product …
Global Interventional Image-Guided Systems market research report provides company profile for St. Jude Medical, Neusoft, Konica Minolta, Samsung Medison, Shimadzu, BenQ Medical Technology, Asahi Roentgen, GE Healthcare, Olympus, Philips Healthcare, Siemens Healthineers, Toshiba Medical Systems and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Image Sensors Market By Types - CCD Image Sensors, Linear Image Sensors, CMOS Im …
The vendor landscape of the U.S. image sensors market includes companies such as Dalsa Corporation, Omnivision Technologies Inc., Micron Technology Inc., and Sharp Microelectronics of the Americas. The market players are witnessing an increased demand for linear image sensors owing to the extensive applications of CMOS (complementary metal-oxide semiconductor) image sensors across a wide range of applications. In fact, the majority of the revenue of these market players comes from